Prostacyclin for lung infection patients on a ventilator
Treatments studied
Part of Blood & lymphatic, Infections, Lungs & breathing clinical trials.
This study tests a medicine called prostacyclin (given through a vein) to see if it helps people on a breathing machine with a lung infection. The goal is to reduce inflammation and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and in the intensive care unit (ICU).
- You have a suspected lung infection, like pneumonia.
- You have been on a breathing machine (ventilator) for less than 24 hours.
- Your blood test shows a certain level of a protein called soluble thrombomodulin (sTM) at 4 or higher.
- You are not pregnant, do not have severe heart failure, and are not in septic shock with very high sTM levels.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two breathing support methods—noninvasive ventilation (a mask that helps you breathe) and high-flow oxygen therapy—to see which works better for people with a sudden worsening of interstitial lung disease (a type of lung scarring) who are in the ICU and need extra oxygen.
This Phase 2 trial tests whether using a blood test that shows clotting strength and “clot breakdown time” can help guide treatment for people in the ICU with acute respiratory failure from infection. If you qualify, the team will use these blood results to decide on clot-related therapy and compare outcomes to standard care.
This trial tests if inhaling a drug called iloprost can help patients who have both severe COPD and high blood pressure in the lungs (pulmonary hypertension). It may improve blood flow and symptoms.
This trial tests an inhaled medicine (TPIP) for people with both lung scarring (interstitial lung disease) and high blood pressure in the lungs (pulmonary hypertension). It aims to see if the drug helps improve exercise ability and symptoms.
This trial tests an inhaled medication called treprostinil (Tyvaso) to see if it can help people with COPD who have low blood oxygen levels. You may qualify if you have chronic bronchitis, use oxygen at rest or during exercise, and meet specific lung function criteria.
This Phase 3 trial tests whether inhaled treprostinil can slow progression of lung fibrosis (scarring) that keeps getting worse despite standard care. It also looks at safety, because inhaled medicine can cause side effects and needs careful monitoring.
Hear when a new Acute Respiratory Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.